Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

BACKGROUND: Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcomes of IN...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Romanowski, Kamila, Chiang, Leslie Y., Roth, David Z., Krajden, Mel, Tang, Patrick, Cook, Victoria J., Johnston, James C.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5583994/
https://ncbi.nlm.nih.gov/pubmed/28870175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2706-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars